Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Exonhit describes novel tubulin polymerization inhibitor

May 9, 2012

Genentech presents first small-molecule Ras inhibitors

May 9, 2012

FDA extends PDUFA date for Marqibo NDA

May 8, 2012

Aeterna Zentaris regains rights to perifosine

May 8, 2012

Pretargeted radioimmunotherapy is safe, specific and fast in patients with colorectal tumors

May 8, 2012

Radius Health scientists design novel SARMs

May 8, 2012

Oncolytics Biotech enters into agreement for phase II Reolysin study

May 7, 2012

Exelixis expands cabozantinib development program

May 7, 2012

MediGene receives final milestone payment for Eligard

May 7, 2012

Novel multikinase inhibitor is active in FLT3-dependent leukemia cells

May 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...